Survival analysis of patients with metastatic head and neck squamous cell carcinoma treated with metastasis-directed radiotherapy and immunotherapy
In patients with metastatic HNSCC, MDRT combined with immunotherapy and chemotherapy can effectively improve local control and OS. These findings warrant further validation through prospective clinical trials.
Authors
- Yecai Huang (ORCID: https://orcid.org/0000-0002-3312-7441)
- Lucia Clara Orlandini (ORCID: https://orcid.org/0000-0002-7033-9689)
- Jinyi Lang (ORCID: https://orcid.org/0000-0002-5406-8671)
- Zhengyi Tang (ORCID: https://orcid.org/0000-0001-9651-5559)
- Shuo Wang (ORCID: https://orcid.org/0000-0002-0990-639X)
- Dongmei Liu (ORCID: https://orcid.org/0000-0002-2056-8600)
- Shun Lu (ORCID: https://orcid.org/0000-0002-1833-475X)
- Jie Zhou (ORCID: https://orcid.org/0000-0002-6991-9766)
- Peng Xu (ORCID: https://orcid.org/0000-0002-1953-0218)
- Mei Feng
Institutions
- North Sichuan Medical University (CN)
- University of Electronic Science and Technology of China (CN)
- Sichuan Cancer Hospital (CN)
Publication Details
- Journal
- Radiation Oncology
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1186/s13014-025-02610-1
- Citations
- 1
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.85